- Diagnostics
- Monday, 13 Apr 2020
Huami partners with Nanshan Zhong's team to fight COVID-19 coronavirus in a joint laboratory
Huami announced a collaboration with the Chinese National Center for Clinical Research on Lung Disease (NCRCRD) and the Guangdong Nanshan Institute for Medical Innovation, led by Dr. Nanshan Zhong, to establish a joint laboratory to develop smart portable devices. Relying on Huami's intelligent portable technologies and powerful calculation algorithms, the laboratory aims to help monitor and manage COVID-19 cured patients through the NCRCRD big data platform. In addition, the laboratory would jointly contribute to an alert and forecast system for epidemics.
"As a collaboration between medical institutes, research and development institutions and companies, we are excited to use our expertise in intelligent portable technologies to promote applied research and facilitate a real transformation in respiratory health" said Wang Huang , founder and chief executive officer of Huami Technology. Guided by its mission to “connect health to technology”, Huami is determined to create a global health ecosystem including devices, data and services, while being a trusted trusted partner of its users.
Dr Nanshan Zhong, 83, an internationally renowned respiratory specialist and member of the Chinese Academy of Engineering, was a pioneer in the fight against SARS in 2013 and is now the chief expert on COVID-19 prevention with the Chinese National Health Commission. Dr. Nanshan Zhong has been fighting on the front line of the coronavirus epidemic since he reported the first person-to-person transmission of COVID-19 in January.
Since the onset of the coronavirus epidemic, Huami has continued its efforts to "connect health to technology". The company has donated RMB 11.5 million worth of medical supplies and equipment since the start of the epidemic. Huami also developed a smart watch for medical personnel in Wuhan , which has a function to alleviate psychological distress.
Related Industry Updates
Brain Aneurysm Treatment Market to Witness Rising Demand by 2020-2027 | Stryker Corporation, MicroPort Scientific Corporation, Terumo Corporation, Penumbra, Medtronic and Johnson & Johnson Services, Inc.
Sep 24, 2020
$4.6m Awarded for Clinical Trials at Northwell's Cancer Institute
Oct 16, 2019
QuEST Global Enhances its Lung Nodule Detection Solution Using Microsoft Azure IoT Central, Azure IoT Edge and Azure Machine Learning
Jun 12, 2020
Shortage of Skilled IT Technicians likely to Affect Laboratory Information Management Systems
Aug 22, 2019
Asia Pacific Companion Animal Diagnostics Market Research Along With COVID-19 Impact Analysis, Advancement and Outlook 2027| Fujifilm Corporation, Skyla Corporation, Virbac
Nov 30, 2020
Asia Pacific Animal Health Market Outlook, Research, Trends and Forecast up to 2027| Virbac, Elanco, Merck & co
Oct 22, 2020
Dominion Diagnostics Offering COVID-19 Serology Antibody Testing
Jun 25, 2020